Skip to main content

Table 2 Model Results from Multivariable Path Analysis of Steps in Cessation Pharmacotherapy Engagement

From: Critical steps in the path to using cessation pharmacotherapy following hospital-initiated tobacco treatment

  Received Meds Inpatient Discharged with Script Used Meds at 1-Month
OR 95% CI OR 95% CI OR 95% CI
Predictor   LL UL   LL UL   LL UL
Warm handoff 0.92 0.67 1.25 1.02 0.75 1.38 0.57 0.41 0.79**
Age, years 0.99 0.97 1 1 0.99 1.01 1.01 0.99 1.02
Female 1 0.73 1.37 1.06 0.77 1.46 0.92 0.65 1.30
Hispanic 1.12 0.56 2.22 1.26 0.69 2.32 1.01 0.47 2.15
White race 1 0.68 1.46 0.77 0.54 1.10 1.20 0.80 1.80
Insurance
 None 0.51 0.23 1.14 0.60 0.26 1.39 1.94 0.94 4.01
 Medicare 1.46 0.96 2.20 1.23 0.81 1.87 0.86 0.55 1.36
 Medicaid 0.91 0.61 1.37 1.45 0.98 2.15 1.22 0.81 1.85
Admitted through ED 2.12 1.52 2.95*** 1.11 0.80 1.52 1.08 0.76 1.52
log(LOSa) 1.01 0.67 1.54 0.85 0.56 1.31 0.56 0.34 0.90*
Smoking related disease 1.27 0.91 1.78 1.21 0.87 1.68 1.04 0.73 1.48
Psychiatric diagnosis 1.73 1.24 1.78** 1.17 0.83 1.64 0.57 0.39 0.83**
HSI 1.21 1.09 1.34*** 1.21 1.10 1.33*** 1.06 0.95 1.19
Used meds prior to admission 2.02 1.45 2.81*** 1.82 1.30 2.55*** 2.00 1.39 2.88***
Confidence 0.80 0.70 0.92** 1.04 0.90 1.20 1 0.86 1.13
Used meds in hospital 6.61 4.66 9.38*** 2.09 1.39 3.15***
Discharged with script for meds 4.88 3.34 7.13***
Total counselling calls 1.22 1.04 1.35***
  1. NRT nicotine replacement therapy, ED emergency department, LOS length of stay, HSI Heaviness of Smoking Index, OR odds ratio, UL Upper Limit, LL lower limit, Meds = Smoking Cessation Medications (nicotine replacement, bupropion, or varenicline)
  2. * p < .05; ** p < .01; *** p < .001
  3. aLength of stay is in hours